Teva ventures to euro and Swissie lands
Teva Pharmaceutical Industries, the Israeli company rated A3/A-, announced today that it would meet euro and Swiss franc bond investors next week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts